Latoya Dickens-Jones
Family · Canton, OHNPI 1790983955
Payments from drug & device makers
Across 573 payments — averaging $22.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- AstraZeneca$1K
- Novo Nordisk$1K
- Boehringer Ingelheim$783
- Lilly USA, LLC$712
- Gilead$691
- plus $7K from 31 others
What the payments were for
- Food & beverage$13,085100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 75 | $1,953 |
| AstraZeneca | 31 | $1,262 |
| Novo Nordisk | 73 | $1,166 |
| Boehringer Ingelheim | 52 | $783 |
| Lilly USA, LLC | 38 | $712 |
| Gilead | 19 | $691 |
| Biohaven Pharmaceuticals, Inc. | 27 | $618 |
| Pfizer | 44 | $617 |
| Johnson & Johnson | 9 | $529 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 20 | $454 |
| Abbott | 9 | $420 |
| Xeris Pharmaceuticals, Inc. | 16 | $411 |
| Corcept Therapeutics | 9 | $326 |
| Vanda Pharmaceuticals Inc. | 17 | $317 |
| Teva Pharmaceuticals USA, Inc. | 12 | $307 |
| Sanofi-aventis U.S. LLC | 13 | $284 |
| Viiv Healthcare Company | 13 | $276 |
| Biohaven Pharmaceutical Holding Company Ltd. | 24 | $243 |
| Indivior Inc. | 13 | $210 |
| GSK | 7 | $188 |
| Alkermes, Inc. | 4 | $178 |
| Almatica Pharma LLC | 10 | $166 |
| Phathom Pharmaceuticals, Inc. | 4 | $151 |
| Sunovion Pharmaceuticals Inc. | 10 | $134 |
| Sage Therapeutics, LLC | 1 | $120 |
| Exact Sciences | 6 | $110 |
| Ultragenyx Pharmaceutical Inc. | 2 | $109 |
| Amgen | 1 | $95 |
| Astellas Pharma US Inc | 3 | $53 |
| SK Life Science, Inc. | 1 | $50 |
| Merck | 3 | $42 |
| Dexcom, Inc. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $23 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Novartis | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $12 |
| Athena Bioscience, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$565
- FARXIGA$448
- Mavyret$375
- NURTEC ODT$351
- SPRAVATO$294
- GVOKE HYPOPEN$249
- Korlym$240
- Wegovy$238
- Creon$214
- FREESTYLE LIBRE 3$150
- Vemlidy$122
- Epclusa$122
- TRULANCE$122
- AIRSUPRA$119
- AJOVY$118
- XARELTO$118
- VIVITROL$115
- XIFAXAN$112
- SOLIQUA 100/33$110
- MOUNJARO$109
How this compares
$13,094 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 28 | $707 |
| Ibuprofen | 35 | $212 |
| Tramadol Hcl | 15 | $194 |
| Atorvastatin Calcium | 37 | $165 |
| Omeprazole | 33 | $124 |
| Levothyroxine Sodium | 15 | $119 |
| Amlodipine Besylate | 40 | $67 |
| Hydrochlorothiazide | 15 | $59 |
| Lisinopril | 19 | $54 |
| Metformin Hcl | 23 | $42 |
| Simvastatin | 24 | $42 |
| Metoprolol Tartrate | 12 | $31 |
| Losartan Potassium | 14 | $25 |
Paid to pharmacies, not to this prescriber.
Other family in Canton
- Brittany McClainCanton$17K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.